For Wealth Managers, DFMs & Private Banks

This page is written for: Wealth managers, discretionary fund managers, private banks and investment distributors who are evaluating how to add differentiated strategies to a product shelf, create a house investment proposition, or make specialist exposure accessible to suitable client segments. Orpheus Capital provides structuring and operational enablement support — we do not provide investment advice to end investors and we do not assess suitability.

Turn Investment Ideas into
Distribution-Ready Propositions

A compelling investment idea must still fit the wealth manager's client profile, advice process, platform infrastructure, reporting expectations and regulatory obligations. Structure and distribution-readiness are part of the product — not an afterthought.

The Starting Point

Product Design Begins with the End Investor

The intended distribution channel should shape the structure from the outset. Decisions made at the design stage — about investor classification, documentation standards, platform requirements and reporting — are difficult and costly to reverse.

A wealth manager or distributor approaching an investment product from the distribution end faces a different set of constraints than an asset manager launching into an institutional channel. The client's classification determines which structures and documentation standards are permissible. The platform or custodian the client uses determines which product types can be held. The advice process and suitability framework determine what documentation the adviser needs to do their job.

Each of these considerations interacts with the others. A product that clears one hurdle — say, regulatory classification — may still fail the operational test if the target platforms will not accept the ISIN type. A product with excellent investment characteristics may be difficult to distribute if its disclosure documents do not support the adviser's suitability process.

Distribution-readiness is not a property that can be added to a product after it is designed. It is the result of building the product with the distribution channel in mind from the first conversation.

Orpheus Capital works with wealth managers and distributors at the point where investment strategy meets product design — helping to evaluate structural options, align product characteristics with distribution requirements and manage the process through to issuance.

Common Objectives

What Wealth Managers Are Trying to Achieve

The starting point is rarely the structure. It is a specific commercial, client-service or operational objective that a structured product might help realise.

Adding differentiated strategies to a product shelf that currently relies entirely on third-party funds or standard discretionary mandates

Creating a house model strategy or branded investment proposition in a listed, transferable format accessible to clients through existing brokers and platforms

Offering international or specialist exposure — commodities, alternatives, thematic strategies — that is not readily available through the firm's standard fund platform

Accessing selected alternative strategies for professionally classified client segments in a format that supports the adviser's suitability and documentation process

Creating a bespoke investment solution tailored to a defined client segment's specific risk profile, income requirements or sustainability preferences

Consolidating several underlying strategies or managers into a single, unified product with integrated valuation, reporting and governance

Improving broker or platform accessibility for a strategy that is currently held outside standard infrastructure, or that requires a listed wrapper to be distributable

Design Considerations

Distribution-Readiness: Questions to Answer at the Design Stage

These factors interact. Addressing them in sequence, from investor outward to infrastructure, avoids structural mismatches that are expensive to correct after launch.

01

Investor Classification

Retail, professional or institutional classification determines which issuance structures, documentation standards and marketing permissions apply.

02

Suitability Framework

What documentation does the advising firm need to support its suitability assessment? The product's risk disclosures and target-market definition must align with the adviser's process.

03

Minimum Investment

What minimum ticket size is operationally and commercially appropriate? This interacts with the investor classification and the issuer's minimum requirements.

04

Liquidity

What liquidity can the structure genuinely offer? This must reflect the actual liquidity of the underlying assets — not the experience the distributor would prefer to offer clients.

05

Valuation Frequency

How frequently can the underlying assets be independently priced? Valuation cadence drives pricing, reporting and investor communication obligations.

06

Disclosure Requirements

Which disclosure documents are required — KID, prospectus, offering memorandum? The applicable regime depends on investor classification, jurisdiction and product type.

07

Platform & Broker Acceptance

Which platforms and brokers need to support the product? Their onboarding criteria will influence the choice of ISIN type, issuer and documentation format.

08

Reporting

What reporting frequency, format and look-through depth do advisers and clients need? Multi-currency, tax-reporting and consolidated-portfolio requirements all need to be specified at the outset.

09

Currency

In which currencies does the product need to be denominated or hedged? Currency share classes add operational complexity and need to be planned for before issuance.

10

Jurisdiction

Where are the investors domiciled and where will the product be distributed? Target markets determine the issuance jurisdiction, regulatory classification and permissible marketing approach.

11

Adviser Education

What do advisers need to understand about the product to distribute it confidently and compliantly? Complexity in the underlying strategy increases the adviser education requirement at launch.

An Important Distinction

Structure Versus Strategy

A product wrapper cannot compensate for unsuitable assets, poor liquidity or inadequate governance. The structure is an enabler — not a solution to underlying investment design problems.

This distinction matters because distributors sometimes approach structuring conversations hoping that a listed wrapper will resolve problems that originate in the investment strategy itself. A strategy whose underlying assets cannot be independently valued cannot be packaged into a product with daily pricing without misrepresenting the risk profile to investors. A strategy with genuinely illiquid underlying positions cannot support redemption terms that assume liquidity exists.

The structural and documentation requirements that govern investment products exist to ensure that investors understand what they are holding, how it is priced and under what conditions they can exit. These requirements cannot be bypassed by selecting a particular issuance format.

The wrapper makes the strategy accessible. It does not make an unsuitable strategy suitable, an illiquid strategy liquid, or a poorly governed mandate well governed.

Orpheus's role at the feasibility stage is to assess whether the proposed strategy, investor profile and distribution objectives support a viable listed product. Where they do not — or where material issues need to be resolved first — we say so clearly at the outset.

The Orpheus Role

How Orpheus Works with Distributors

Orpheus Capital supports wealth managers and distributors from initial feasibility through to issuance and ongoing product support. We do not provide investment advice to end investors, assess suitability, or raise capital.

  • Assess distribution objectives — understanding the target investor, intended distribution channel, platform requirements and commercial objectives before any structural work begins
  • Coordinate structuring requirements — translating distribution requirements into product design parameters: investor classification, documentation standards, disclosure format and mandate governance
  • Engage appropriate issuance partners — identifying issuers, administrators and legal counsel appropriate for the specific mandate, investor profile and jurisdiction
  • Align product design with operational requirements — addressing valuation methodology, reporting infrastructure, NAV governance and platform compatibility before issuance
  • Support documentation and implementation — managing the documentation, review and issuance process to ensure all components are in place at launch
  • Provide ongoing enablement — continuing to coordinate between the distributor and service providers after issuance, including any product updates or reporting changes

Questions We Hear Often

Frequently Asked Questions

Can a wealth manager create a bespoke investment product?

Yes, subject to appropriate structuring, legal and regulatory considerations. A wealth manager or distributor can work with an issuer to establish a product structured around a defined investment mandate — including a house model, a white-labelled strategy or a bespoke allocation for a client segment. The product needs to be designed with the target investor's classification, suitability framework and platform requirements in mind from the outset. Orpheus can assess the feasibility of a proposed mandate and outline the structuring options available.

Can the product carry the wealth manager's brand?

Products can be structured with naming and documentation that reflects the distributor's brand, subject to the applicable regulatory and disclosure requirements. The extent to which branding is possible depends on the jurisdiction, the investor classification and the product documentation standards that apply. This is a question to address during the initial structuring conversation, not after the product is launched.

Can it be added to an investment platform?

A listed product with an ISIN can in principle be held on platforms and through brokers that support the relevant product type. Whether a specific platform will accept the product depends on its own onboarding criteria, which are set by the platform provider and are not within Orpheus's control. Orpheus can help identify structuring approaches that align with common platform and broker requirements, but acceptance by any specific institution cannot be guaranteed.

Who determines investor suitability?

Suitability assessment is the responsibility of the distributor or adviser recommending the product to the end investor. Orpheus Capital does not provide investment advice to end investors and does not make suitability assessments. The structuring process can help ensure the product's documentation, risk disclosures and target-market definition are appropriately framed to support the adviser's suitability process, but the suitability determination itself rests with the distributing firm.

Can several managers be combined in one product?

Yes. Multi-manager or multi-strategy exposure can be combined within a single listed structure, subject to appropriate mandate design and governance. This approach requires clear specification of how allocations are determined, how each manager's contribution is valued, and how the consolidated product is administered and reported. Orpheus has experience structuring multi-manager products and can outline the operational requirements as part of the initial feasibility discussion.

What reporting can be provided?

Reporting requirements should be specified as part of the structuring process. Standard outputs typically include periodic NAV statements, transaction confirmations and year-end reporting. The frequency, format, look-through depth, multi-currency requirements and adviser-specific reporting needs all need to be agreed with the relevant service providers before issuance. Retrospective changes to reporting infrastructure are operationally costly, so these requirements should be mapped out at the design stage.

Can Orpheus guarantee platform or broker acceptance?

No. Platform and broker acceptance depends on each institution's own onboarding criteria, product governance frameworks and operational requirements — none of which are within Orpheus's control. Orpheus can help structure a product in ways that are likely to be compatible with common platform and broker requirements, and can advise on the kinds of documentation and product features that tend to support acceptance. But acceptance by any specific platform or broker is never guaranteed and should not be assumed at the planning stage.

Begin the Conversation

If you have a proposition to explore

Explore a Product Proposition

A structured conversation about your distribution objectives, intended client segment, platform requirements and investment mandate — before committing to any structural approach. We identify what needs to be resolved first.

Get in Touch
If you have a specific question

Request a Distribution-Readiness Discussion

Not sure whether a proposed strategy is structurally viable for your distribution channel? We can review the key considerations — investor classification, platform compatibility, documentation requirements — in the context of your specific proposition.

Send Us a Question

This page is intended for professional and institutional readers who are considering the use of listed structured products in a capital-raising or distribution context. It does not constitute investment advice, financial product advice, legal advice or a solicitation to invest. Orpheus Capital provides structuring and operational enablement services and does not provide investment advice to end investors. All structural options are subject to applicable regulatory, legal and exchange requirements in the relevant jurisdiction. Nothing on this page should be interpreted as a guarantee of outcome, regulatory approval or investor acceptance.

Orpheus Capital. For professional and institutional enquiries only.